Physician profile
Andy M Fine
NPI 1245261965
$806.80
in general payments reported to CMS, 2019-2025
15 companies · $17.64 in 2025
The $17.64 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.90 · 2021: $44.28 · 2022: $264 · 2023: $306 · 2024: $157 · 2025: $17.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $481.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $480.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $156.82 | 2021-2024 | |
| Becton, Dickinson and Company | $155.00 | 2022 | |
| Skeletal Dynamics INC | $131.33 | 2023 | Implate, Align, Ijs |
| Celgene Corporation | $77.53 | 2024 | Reblozyl |
| Boston Scientific Corporation | $48.99 | 2023-2024 | Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $45.00 | 2022 | |
| Nevro Corp. | $44.94 | 2023 | Senza |
| Gilead Sciences, INC. | $42.11 | 2019-2022 | |
| Dexcom, INC. | $20.52 | 2024 | Dexcom G6 Transmitter |
| Viiv Healthcare Company | $19.39 | 2023 | Apretude |
| Astrazeneca Pharmaceuticals Lp | $18.85 | 2021 | |
| Exact Sciences Corporation | $17.64 | 2025 | The Cologuard Plus Collection Kit |
| Inspire Medical Systems, INC. | $16.03 | 2023 | Inspire |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.65 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andy Fine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.